Latest news with #DarrenDavis
New York Post
23-05-2025
- New York Post
Teen arrested in killing of NYC man on his way to buy flowers to put at his mom's grave for Mother's Day: Cops
Investigators arrested a Bronx teenager for the May 10 shooting of a 30-year-old man who was killed on his way to purchase flowers to place on his mom's grave for Mother's Day, police and family said. The suspect, a 15-year-old boy, was arrested and charged Monday with second-degree murder in the killing of Darren Davis, the NYPD announced Wednesday. 3 A 15-year-old was charged with murder for the fatal shooting of Darren Davis, 30, who was on his way to buy flowers for his mom to leave on her grave on Mother's Day. FREEDOMNEWS TV Advertisement The shooting occurred at around 8:30 p.m. in the Mott Haven neighborhood of the Bronx when the teen opened fire, striking Davis and a 42-year-old woman near the corner of Willis Avenue and 138th Street, cops said. Davis was struck in the chest and collapsed in front of a bodega, just steps from the smoke shop where he had finished working his shift, police said. He was pronounced dead at Lincoln Hospital. The woman was shot in the leg and was taken to the hospital in stable condition. Neither victim knew the gunman, but police weren't able to say for sure whether the victims were targeted or innocent bystanders. Advertisement Davis' family was almost at a loss for words over what they described as a senseless killing and devastating loss as they slammed his accused murderer. 3 An overturned coffee cup where police investigated the fatal shooting of Darren Davis, 30. FREEDOMNEWS TV 'I don't — I have no words for it, you understand? Like, you took somebody's life,' the victim's cousin, Lashaye Davis, said of his killer. 'You kind of – not kind of – you actually destroyed our family behind that.' Advertisement Lashaye, 31, said that Darren was 'lovable' and 'full of joy and life.' 'He was just an outstanding person that was there for everybody,' she told The Post. 3 Police at the scene of the fatal shooting of Darren Davis, 30. FREEDOMNEWS TV She was glad the alleged shooter – even though he is still just a teenager – is in custody. Advertisement 'I really don't have no remorse for the little boy,' Lashaye said. Darren's grandmother, Alfair Davis, 81, was relieved as well that they caught the suspect. 'I was grateful and I am glad he is in custody.' She said she will always remember her grandson with fondness. 'Darren was the type of person [who] never got into no problems,' she said. 'He never had a problem with nobody. He was just a beautiful person.' It was not immediately clear whether the suspected killer — whose name hasn't been released because he's a minor — will face additional charges for shooting and wounding the female victim. The arrest of the teen comes amid a spate of gang-related youth violence in recent weeks in the south Bronx. Advertisement On May 12, Evette Jeffrey, a 16-year-old innocently riding her scooter near a schoolyard, was shot in the head and killed by a stray bullet fired by a 14-year-old who was handed a gun by a 13-year-old, according to cops. Just 24 hours later, an 11-year-old boy was injured when a stray bullet fired by a teen involved in a gang dispute went flying through the rear window of the car he was a passenger in. He suffered injuries related to the shattered glass, while the adult driver was shot in the shoulder.
Associated Press
25-04-2025
- Health
- Associated Press
Precision for Medicine and PathAI Announce Strategic Collaboration to Advance AI-Powered Clinical Trial Services and Biospecimen Products
Collaboration will deliver innovative AI-powered pathology tools and quality control enhancements to accelerate clinical trials and biomarker discovery BOSTON and FREDERICK, Md., April 25, 2025 /PRNewswire/ -- Precision for Medicine, a leading provider of next generation drug development research and services, and PathAI, a global leader in digital pathology, today announced a strategic collaboration to partner on developing novel AI-based technologies and to integrate PathAI's advanced digital pathology and analysis capabilities across Precision for Medicine's clinical trial and biospecimen operations. This collaboration includes use of several PathAI technologies and establishes an agreement to offer novel tools and analytical services that address emerging needs in biomarker discovery, spatial biology, and tissue-based clinical research. Through this collaboration PathAI's tools and services will help augment Precision for Medicine's proprietary pipeline providing biopharma clients with access to imaging workflows offered through Precision for Medicine's integrated laboratory and clinical trial services. 'Together, we're deploying tools that add critical quality control steps to tumor biopsy workflows and apply machine-based learning and unsupervised algorithms early in the development cycle to help identify which biomarkers are most relevant for clinical efficacy,' said Darren Davis, PhD, Senior Vice President Global Digital Pathology, Genomics and Liquid Biopsy Solutions. 'Precision for Medicine's CLIA compliant laboratory enables precise patient stratification and accelerate decision-making in clinical trials, ultimately supporting success in areas of high unmet need.' As part of the agreement, Precision for Medicine will deploy select tools from PathAI, including AISight®, a digital pathology image management system, and other AI-powered algorithms to enhance biospecimen and clinical trial services. These tools will enable the application of validated, algorithm-based quality control steps to biospecimen analysis, improving consistency and data reliability. The collaboration will also support the use of PathAI's leading AI capabilities leveraging best in class machine learning based models to enhance Precision for Medicine multi-modal datasets. The technology reduces large, complex biomarker panels to scalable, and actionable, biomarkers to help interpret complex tissue biology to complement translational research programs. Additionally, the companies will work together to analyze complex tissue biology empowering biopharma clients to understand and identify the right patients for the right therapies, faster. 'At PathAI, our mission is to harness the power of artificial intelligence to improve the accuracy, depth, and efficiency of pathology-driven insights,' said Andy Beck, MD, PhD, Co-founder and CEO of PathAI. 'We are thrilled to collaborate with Precision for Medicine to help advance our mission and deliver differentiated value to our mutual customers.' Precision's collaboration with PathAI brings unique value to biopharma clients by combining these AI tools with proprietary wet lab infrastructure, centralized clinical trial operations, and scientific oversight. The innovative tools generated through this collaboration will only be available through Precision for Medicine's services, providing a level of integration and customization not offered elsewhere in the industry. 'This collaboration enhances how we're using our biospecimen business by enabling deeper, more informative analyses of the tissue samples we provide to our clients,' said Cullen Taylor, MD, Medical Director at Precision for Medicine. 'We're adding an entirely new layer of cellular-level insight on top of already well-annotated sequenced samples, going far beyond what traditional pathology assessments can offer. It's a meaningful step forward in how we support biomarker discovery, enhancing datasets for diagnostic validation and therapeutic development.' About Precision for Medicine Precision for Medicine is the first biomarker-driven clinical research and development services organization supporting life sciences companies in the use of biomarkers essential to targeting patient treatments more precisely and effectively. Precision applies a transformational approach to clinical research that integrates clinical trial design and execution with deep scientific knowledge, laboratory expertise, data sciences and advanced manufacturing solutions. This convergence is driving faster clinical development and approval. Precision for Medicine is part of Precision Medicine Group, with 3,500 people in 40 locations globally across North America, Europe and Asia-Pacific. For more information, visit Contact Andie Lunkenheimer [email protected] About PathAI PathAI is a leading provider of integrated AI and digital pathology solutions dedicated to transforming diagnostic accuracy and operational efficiency in pathology labs worldwide. Through innovative technologies and strategic partnerships, PathAI aims to enhance patient outcomes and drive the future of medical diagnostics. For more information, please visit Contact Owen Blaschak [email protected] Footnote 1AISight is for Research Use Only in the US; AISight Dx is CE-IVDR in Europe and UKCA in UK View original content to download multimedia: SOURCE PRECISION FOR MEDICINE
